Risk factors and risk reduction of breast and ovarian cancer.
about
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityPrevention of mammary carcinogenesis by short-term estrogen and progestin treatmentsEstrogen, progesterone and epithelial ovarian cancerSerum harvested from heifers one month post-zeranol implantation stimulates MCF-7 breast cancer cell growthEstrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Cancer risk in mothers of men operated for undescended testis.Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.Ovarian cancer (advanced)Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies.Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.Incidence of breast and gynaecological cancers by ethnic group in England, 2001-2007: a descriptive study.Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort.Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesisFSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas.Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutationsVitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish populationEpithelial ovarian cancer. Risk factors, screening and the role of prophylactic oophorectomy.Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment.Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.Is dairy intake associated to breast cancer? A case control study of Iranian women.In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality.Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause.Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis.Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.Effects of lifelong exercise training on mammary tumorigenesis induced by MNU in female Sprague-Dawley rats.Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60-64 years.
P2860
Q24200437-57540387-D637-4CD9-ADD7-8D0D4C09B4D5Q24803836-AA116701-9125-4F36-9FB9-2CBE6113F276Q24805637-14E841FA-24E6-44AF-8FA2-BAAE1C61969CQ28388804-2081E5BF-87FF-4A17-B4B2-DB8AF235F024Q33642747-DC4DB0A2-B556-456E-9EEF-909859FD0D88Q33775569-039A8F39-7B79-4938-AC7D-9A810EB1A4E4Q33944881-0542ACB4-5677-40E4-9607-0999A7DBB09FQ34010642-F83FB729-8542-4E61-8231-BDAB025AF87FQ34545168-0E2A21F3-E9D1-4068-AEDB-C89E953D4DDEQ34572558-B392C830-69E6-4858-A725-AE51FFFE7E37Q34795858-F34E197C-8DAB-4FB7-B936-E5F8EDCD5FEAQ34991318-C4431747-F7C0-42B1-AEF5-CEE93D2637B2Q34993359-E7CBD390-2F5C-45AF-AD7B-181B6F279A75Q35575288-5F8C8850-0763-417E-9397-637020E307C0Q35929364-047092C9-5096-4532-ACA2-F03FB7988B4AQ36472462-70A06A81-3B66-42CE-A080-8FF268D2085DQ36524235-58D4AC5B-49F2-4B80-9622-E07375C13C26Q36638586-97B283D5-557B-44E4-8258-F447DF5A96F2Q36765989-711F3DCA-0C04-4F8B-B079-55E2FAD20052Q37218434-E78FD579-117E-46D2-8CDE-F3A95FBBB6D1Q37218593-D4A7C3B7-1CF0-4885-A8C7-CC4205F52AF1Q37357759-7CBC7FDA-E78E-4EFC-940E-ADD04F189907Q37619695-6896C03F-291A-4DF2-9958-959BFACBF9D8Q37666512-4F557FD2-1DC7-42DB-9DB2-250221A17B3EQ37693879-90F1892A-5173-4A8B-AE3C-CAC9D5FBD361Q38399395-4C1C23B2-71E6-4073-B458-AF77C84A185BQ38835733-34082C46-8422-4C3B-B016-27B1D43BF1DEQ39968868-F41203D5-9827-498A-B2CD-A3F5E4E1C6F8Q44492636-582F0EB9-3486-4473-8E22-0127326D0233Q46343159-BEF1E740-89D1-42BF-AF27-1BCAB4016ED9Q46555307-86DA87D7-FD6A-4556-AED5-5DA8465673F2Q47235498-BF8F8F87-7845-48D3-8A32-A639814F86D2Q48120015-6786E220-3F68-4AAC-A572-18710709F38DQ49857214-ABC09EF9-21F5-473A-A282-45F31554B7EBQ50907125-9C39C9AB-8072-463E-A1D2-3117EFD2C9C4Q51922699-5C611007-4F5C-4F64-86C7-EC98B9711031
P2860
Risk factors and risk reduction of breast and ovarian cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Risk factors and risk reduction of breast and ovarian cancer.
@ast
Risk factors and risk reduction of breast and ovarian cancer.
@en
type
label
Risk factors and risk reduction of breast and ovarian cancer.
@ast
Risk factors and risk reduction of breast and ovarian cancer.
@en
prefLabel
Risk factors and risk reduction of breast and ovarian cancer.
@ast
Risk factors and risk reduction of breast and ovarian cancer.
@en
P1476
Risk factors and risk reduction of breast and ovarian cancer.
@en
P2093
Cecile T M Brekelmans
P356
10.1097/00001703-200302000-00010
P577
2003-02-01T00:00:00Z